Glucotrack announces 1-for-20 reverse stock split
RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ:GCTK), a medical device company specializing in diabetes care technology, has announced a 1-for-20 reverse stock split of its issued and outstanding common stock,
ZK International Group Announces 1-for-7 Reverse Stock Split
ZK International Group Co., Ltd. (Nasdaq: ZKIN) ("ZK International" or the "Company"), a leading engineering Company focused on high-performance steel products, announces a 1-for-7 reverse split of its ordinary shares approved by the Company's Board of Directors on January 14,
Focus Universal Announces Reverse Stock Split
ONTARIO, CA / ACCESS Newswire / January 29, 2025 / Focus Universal inc. (Nasdaq:FCUV) ("Focus" or the "Company"), a provider
Aclarion announces reverse stock split effective January 29
Aclarion , Inc. (NASDAQ:ACON), a medical laboratory services provider with a current market capitalization of just $0.29 million, has announced a reverse stock split of its common stock at a ratio of 1-for-335,
ZK International to implement 1-for-7 reverse stock split
ZK International Group (ZKIN) announces 1-for-7 reverse stock split to meet NASDAQ listing requirements, effective Jan.
Eyenovia Announces 1-for-80 Reverse Stock Split
(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today announced that its Board of Directors approved a 1-for-80 reverse stock split (the “Reverse Stock Split”) of its outstanding shares of common stock,
Aclarion announces revised reverse stock split details
BROOMFIELD, CO - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company with a current market capitalization of $0.4 million and trading at $0.03 per share, has announced an update to the timing and ratio of its forthcoming reverse stock split.
Aclarion Announces Revised Split Ratio and Timing for Reverse Stock Split
Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help
Crown Announces Effective Date of Reverse Stock Split
The Company's Board of Directors approved the reverse stock split at a ratio of 1-for-150 shares on January 25, 2025, following approval for the action by Crown's stockholders at a special stockholders meeting on January 14, 2025.
Karyopharm increases authorized shares, approves reverse split
Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a biopharmaceutical company with a market capitalization of $83.66 million and currently trading at $0.66 per share, held a Special Meeting of Stockholders ...
The National Law Review7d
The State of Play for Reverse Stock Splits by Nasdaq- and NYSE-Listed Issuers
Issuers listed on the Nasdaq Stock Market and the New York Stock Exchange (NYSE) often conduct reverse stock splits to maintain compliance with each exchange’s US$1.00 minimum share price requirement.
Glucotrack Announces Reverse Stock Split
February 4, 2025RUTHERFORD, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization ...